Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:47 PM
Ignite Modification Date:
2025-12-24 @ 2:47 PM
NCT ID:
NCT01461759
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed chemotherapy naïve endometrial cancer
* One of following histology Endometrioid, UPSC, CCCa, squamous, adenosquamous, mixed
* FIGO stage IVb or recurrent endometrial cancer (incurable by surgery and/or RT)
* At least one measurable lesion by RECIST on CT
* ECOG PS: 0-2
* Age: 20-75
* Adequate organ function BM: ANC≥1,000/mm3, Plt≥100X103/mm3 Kidney: Creatinine\<1.25 × UNL이고, GFR ≥ 60 Liver: AST, ALT\< 3×UNL, T- bil\<1.5 mg/ mm3
* Informed Consent
* Contraception during study period
Exclusion Criteria:
* Previous chemotherapy
* RT, hormone therapy, or immunotherapy within 1 month
* Other malignant disease
* Uncontrolled medical disease
* Infection requiring antibiotics
* Symptomatic CHF, RF, Angina, Arrhythmia, etc.
* Neurosis or psychosis
* Pregnancy, breast-feeding
* Etc.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
20 Years
Maximum Age:
75 Years
Study:
NCT01461759
Study Brief:
Protocol Section:
NCT01461759